John Wayne Cancer Institute

Htg Molecular Diagnostics, Inc.

B J Kerns

Dave S B Hoon

Hui Wang

Bruce Seligmann

Krishna Maddula

Tom Vasicek

Zhenquiang Lu

Christopher Roberts

Disclosed are methods for determining whether a melanocyte-containing sample (such as a nevus or other pigmented lesion) is benign or a primary melanoma. These methods can include detecting (at the molecular level, e.g., mRNA, miRNA, or protein) the expression of at least two disclosed genes in a biological sample obtained from a subject. Also provided are arrays and kits that can be used with the methods.

Molecular malignancy in melanocytic lesions

Growing community of inventors

Madison, WI, United States of America

B J Kerns